Financials

	2022	2023
Net sales	14.52M 12.71M 11.71M 10.87M 20.64M 1.38B 20.92M 140M 54.56M 680M 54.52M 53.32M 2.36B	15.3M 13.4M 12.34M 11.45M 21.75M 1.46B 22.04M 148M 57.48M 716M 57.44M 56.18M 2.48B
Net income	-117M -102M -94.12M -87.37M -166M -11.13B -168M -1.13B -438M -5.46B -438M -429M -18.94B	-101M -88.36M -81.38M -75.54M -143M -9.62B -145M -974M -379M -4.72B -379M -371M -16.38B
Net Debt	-70.34M -61.6M -56.74M -52.67M -100M -6.71B -101M -679M -264M -3.29B -264M -258M -11.42B	-1.47M -1.29M -1.19M -1.1M -2.09M -140M -2.12M -14.19M -5.52M -68.83M -5.52M -5.4M -239M

* Estimated data More financial data

Company Profile

DTech Liquidating, Inc., formerly DermTech, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code. The Company has no business operations.

Employees

Sector

Investment Holding Companies

More about the company

Market Cap	35 30.65 28.23 26.21 49.77 3.34K 50.44 337.96 131.53 1.64K 131.44 128.56 5.68K	P/E 2022	-0.46x	P/E 2023	-0.57x
Enterprise Value	-1.47M -1.29M -1.19M -1.1M -2.09M -140M -2.12M -14.19M -5.52M -68.83M -5.52M -5.4M -239M	EV / Sales 2022	-1.16x	EV / Sales 2023	3.82x
Free-Float	98.04%	Yield 2022 *	-	Yield 2023	-

25-08-12	DermTech, Inc. Went Out of Business	CI
25-05-22	Fourth Motion for Exclusivity Period Extension Approved For DermTech, Inc.	CI
25-04-01	Third Motion for Exclusivity Period Extension Approved For DermTech, Inc.	CI
25-03-03	Bankruptcy Judge Changed for DermTech, Inc.	CI
25-01-28	Second Motion for Exclusivity Period Extension Approved For DermTech, Inc.	CI
24-12-12	First Amended Disclosure Statement Approved for DermTech, Inc.	CI
24-12-11	Combined First Amended Joint Liquidation Plan and Disclosure Statement Filed by DermTech, Inc.	CI
24-11-12	Motion for Exclusivity Period Extension Approved For DermTech, Inc.	CI
24-11-06	Joint Liquidation Plan and Disclosure Statement Filed by DermTech, Inc.	CI
24-09-27	First Motion for Exclusivity Period Extension Filed by DermTech, Inc.	CI
24-08-29	DERM-JES Holdings, LLC completed the acquisition of Substantially All Assets from DermTech, Inc. (OTCPK:DMTK.Q).	CI
24-08-21	Motion for Asset Sale Approved for DermTech, Inc.	CI
24-08-20	DERM-JES Holdings, LLC enter into a winning bid to acquire Substantially All Assets from DermTech, Inc. (OTCPK:DMTK.Q).	CI

24-04-19	Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	MT
24-04-19	BTIG Downgrades DermTech to Neutral From Buy	MT
24-03-07	BTIG Adjusts DermTech's Price Target to $2 From $4, Maintains Buy Rating	MT
24-03-05	Stephens Trims Price Target on DermTech to $1.50 From $2.50, Keeps Equalweight Rating	MT
23-08-07	BTIG Adjusts Price Target on DermTech to $5 From $6, Maintains Buy Rating	MT

24-09-02	DermTech Completes Transaction for Asset Sale; Operations Continue Under New Ownership and Management	AQ
24-06-18	DermTech Files for Voluntary Chapter 11 Protection	BU
24-06-13	SciBase strengthens the US organization with experienced leader in dermatology	AQ
24-05-14	DermTech Reports First-Quarter 2024 Financial Results	BU
24-05-10	DermTech : Accelaration/Increase of Financial Obligation - Form 8-K	PU

Manager	Title	Age	Since
Kevin Sun DFI	Director of Finance/CFO	48	2019-09-11
Bill Zondler CTO	Chief Tech/Sci/R&D Officer	-	-
Steven Stone CTO	Chief Tech/Sci/R&D Officer	-	2022-07-27

DermTech, Inc. Stock Nasdaq

Stocks

VGG2379F1247

Investment Holding Companies

Valuation: DermTech, Inc.

Latest news : DermTech, Inc.

Analysts' recommendations: DermTech, Inc.

Press Releases: DermTech, Inc.

Managers and Directors: DermTech, Inc.

Shell Companies

Financials

Company Profile

Director	Title	Age	Since
Matthew Posard CHM	Chairman	59	2016-06-30
Herm Rosenman BRD	Director/Board Member	78	2016-12-31
Cynthia Collins BRD	Director/Board Member	68	2018-05-23

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DERMTECH, INC.	-.--%	-.--%	-	-	35
IQM QUANTUM COMPUTERS OYJ	+0.58%	0.00%	-	-	3.67B
SECURITIZE CORP.	-11.12%	-16.31%	-1.07%	-	1.86B
EINRIDE AB	+1.78%	+24.67%	-	-	1.2B
CHURCHILL CAPITAL CORP XI	-4.01%	+5.00%	-	-	959M
CHURCHILL CAPITAL CORP VII	-0.30%	-.--%	-.--%	-3.20%	915M
PRIME BEING CORP.	-35.29%	-.--%	+44.74%	+391.07%	797M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.05%	+0.20%	-	-	643M
CENTIEL AG	-4.61%	-17.90%	+282.78%	-71.10%	615M
ACC AVIATION HOLDINGS LTD.	-1.57%	-.--%	+1,150.00%	+284.02%	624M
Average	-5.60%	+0.59%	+295.29%	+150.20%	1.25B
Weighted average by Cap.	-4.64%	-0.07%	+192.10%	+149.85%